PlumX Metrics
Embed PlumX Metrics

Polymeric nanosystems for cardiovascular therapeutics

Polymeric Nanosystems, Page: 699-722
2023
  • 0
    Citations
  • 0
    Usage
  • 6
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Book Chapter Description

Cardiovascular disorders are the leading risk factor and a common cause of death in a substantial proportion of the world’s population. The incidence of cardiovascular disease is growing due to a rise in diets high in saturated fat, salt, and sugar. It also occurs in people who live sedentary lifestyles and have obesity. Currently, the only choices for treating cardiovascular conditions are oral medications or invasive surgery. There is a tremendous need for new therapeutics in this field of medicine to enhance clinical care. Nanotechnology could make a major contribution to more successful disease treatment, better early diagnosis, and a lower risk of side effects. A wide range of theranostic nanosystems has been developed over the last few decades. The flexibility, adaptability, and biocompatibility of adequately formulated composites have been used to make remarkable development in drug delivery using polymeric theranostic nanosystems.

Bibliographic Details

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know